SFI Health™ Launches Equazen® Supplements in Portugal for Cognitive Support
SFI Health™ EMEA, the regional arm of SFI Health™, a global leader in natural healthcare, is excited to announce the upcoming launch of Equazen® products in Portugal. SFI Health™ is renowned for specializing in clinically researched products targeting the microbiome, cognition, and overall well-being.
This marks a significant milestone in the company’s European expansion. The launch follows the exclusive licensing agreement signed in February 2024 with Eqyon Healthcare Solutions, a local distributor known for its expertise in healthcare products. Under the agreement, Eqyon will leverage its sales and marketing capabilities to distribute the Equazen® product range across pharmacies and drugstores in Portugal.
Equazen® is a well-established global brand that offers scientifically-backed nutritional supplements aimed at supporting brain health and cognitive function. The products feature a unique blend of essential fatty acids, specifically omega-3 and omega-6, which have been proven in over 15 clinical studies to promote learning, focus, and healthy brain development. This combination of essential nutrients has made Equazen® a trusted name for those seeking effective cognitive health support.
Matthew Brabazon, Managing Director of SFI Health™ EMEA, shared his excitement about the launch, saying, “We are delighted to offer our science-based Equazen® solutions to Portuguese consumers, who are increasingly becoming more conscious of their cognitive health. Our entry into the Portuguese market is an important step in our broader strategy to expand our presence in the region. We are committed to growing our partner network and customer base, and this launch marks a key part of that journey.”
Nuno Carvalho, CEO of Eqyon Healthcare Solutions, expressed confidence in the impact that Equazen® will have on the Portuguese market. “We believe that Equazen® products will make a significant difference in our market due to their high-quality ingredients and well-documented benefits. We are proud to reintroduce Equazen® to Portugal and look forward to working closely with SFI Health™ EMEA to further strengthen the trust of both healthcare professionals and consumers in natural, science-backed solutions.”
The market for brain health supplements is rapidly expanding, driven by growing awareness of cognitive and mental health. In Europe, it is projected that the brain health supplement segment will grow at a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030. This growth is fueled by increasing consumer interest in improving brain function and mental well-being, making Equazen® products an ideal fit for the expanding market.
SFI Health™ EMEA, along with its Equazen® products, is already present in several European markets, including Spain, the UK, Switzerland, Poland, the Czech Republic, Slovakia, the Netherlands, and the Nordic and Baltic regions. The company plans to continue expanding the distribution of Equazen® to maximize the brand’s sales potential, capitalizing on the growing demand for brain health supplements across Europe.
About SFI Health™
SFI Health™ is a global leader in natural healthcare, dedicated to the design, development, and commercialization of clinically-investigated products that focus on the microbiome, cognition, and wellness. With a strong belief in the healing power of natural products, SFI Health™ combines a rigorous pharmaceutical approach with the benefits of naturally derived solutions.
Headquartered in Australia, SFI Health™ operates through a wide network of trusted business partners and markets its own brands in over 50 countries. The company’s EMEA regional office, located in Lugano, Switzerland, manages commercial operations across Europe, the Middle East, and Africa.
SFI Health™ is committed to building trust in natural healthcare by sharing cutting-edge research, technical expertise, and comprehensive business resources with consumers, healthcare professionals, and partners worldwide. Their focus on research-backed, naturally derived products continues to drive their growth and expansion into new markets, including the exciting launch of Equazen® in Portugal.
